Cytta Corp.
CYCA
$0.02
$0.0221,900.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.20K | 38.20K | 1.20K | 800.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20K | 38.20K | 1.20K | 800.00 | -- |
| Cost of Revenue | 18.60K | 18.50K | -- | -- | -- |
| Gross Profit | -17.40K | 19.80K | 1.20K | 800.00 | -- |
| SG&A Expenses | 562.00K | 642.20K | 700.60K | 1.30M | 905.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 580.70K | 660.70K | 700.60K | 1.30M | 905.70K |
| Operating Income | -579.40K | -622.40K | -699.30K | -1.29M | -905.70K |
| Income Before Tax | 6.22M | -687.10K | -763.00K | -1.45M | -988.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.22M | -687.10K | -763.00K | -1.45M | -988.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.22M | -687.10K | -763.00K | -1.45M | -988.50K |
| EBIT | -579.40K | -622.40K | -699.30K | -1.29M | -905.70K |
| EBITDA | -570.30K | -612.10K | -689.00K | -1.28M | -895.20K |
| EPS Basic | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 470.14M | 469.88M | 468.15M | 458.79M | 440.66M |
| Average Diluted Shares Outstanding | 543.73M | 469.88M | 468.15M | 458.79M | 440.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |